Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review

Código QR

Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review

Benchalak Maneeton,1 Narong Maneeton,1 Surinporn Likhitsathian,1 Pakapan Woottiluk,2 Punjaree Wiriyacosol,1 Vudhichai Boonyanaruthee,1 Manit Srisurapanont1 1Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 2Psychiatric Nursing Division, Faculty of Nursing,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Maneeton B, Maneeton N, Likhitsathian S, Woottiluk P, Wiriyacosol P, Boonyanaruthee V, Srisurapanont M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Escitalopram Duloxetine Efficacy Acceptability Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/2026a855f7864a32bf5c2cef725589dc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
por: Maneeton B, et al.
Publicado: (2017)

Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis
por: Maneeton N, et al.
Publicado: (2018)

Risperidone for children and adolescents with autism spectrum disorder: a systematic review
por: Maneeton N, et al.
Publicado: (2018)

Efficacy and Safety of Cordyceps militaris as an Adjuvant to Duloxetine in the Treatment of Insomnia in Patients With Depression: A 6-Week Double- Blind, Randomized, Placebo-Controlled Trial
por: Jiaojiao Zhou, et al.
Publicado: (2021)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
por: Kishi T, et al.
Publicado: (2017)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
por: Harada E, et al.
Publicado: (2016)

Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder
por: Haider M, et al.
Publicado: (2017)

Comparative efficacy, acceptability, and tolerability of dexmethylphenidate versus placebo in child and adolescent ADHD: a meta-analysis of randomized controlled trials
por: Maneeton N, et al.
Publicado: (2015)

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
por: Novick D, et al.
Publicado: (2016)

Update on duloxetine for the management of stress urinary incontinence
por: Maya Basu, et al.
Publicado: (2008)

Effects of escitalopram with a Chinese traditional compound Jiuweizhenxin-keli on mismatch negativity and P50 in patients with major depressive disorders
por: Kuang W, et al.
Publicado: (2016)

An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis
por: Kuga A, et al.
Publicado: (2017)

Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population
por: Jiang KD, et al.
Publicado: (2017)

Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
por: Russell J, et al.
Publicado: (2010)

An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life
por: Kuga A, et al.
Publicado: (2017)

Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety
por: Wang G, et al.
Publicado: (2018)

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
por: Huang J, et al.
Publicado: (2018)

Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
por: Kuga A, et al.
Publicado: (2019)

Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation
por: Soraia Silva, et al.
Publicado: (2021)

EFFICACY AND SAFETY OF DULOXETINE IN THE TREATMENT OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: I Putu Eka Widyadharma, et al.
Publicado: (2021)

Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment
por: Xue-Qin Wang, et al.
Publicado: (2021)

Long-term administration of escitalopram in patients with social anxiety disorder in Japan
por: Asakura S, et al.
Publicado: (2016)

Optimized regimens of combined medications for the treatment of major depressive disorder: a double-blind, randomized-controlled trial
por: Zuilhof Z, et al.
Publicado: (2018)

Escitalopram, bupropion, lurasidone, lamotrigine and possible vortioxetine overdose presented with serotonin syndrome and diffuse encephalopathy: A case report
por: Suthimon Thumtecho, et al.
Publicado: (2021)

Validation of a quick and simple chromatographic method for simultaneous quantification of sertraline, escitalopram, risperidone and paliperidone levels in the human plasma
por: Jeremić Aleksandra, et al.
Publicado: (2021)

Clinical meaningfulness of duloxetine's effect in Chinese patients with chronic pain due to osteoarthritis: post hoc analyses of a phase 3 randomized trial
por: Yue L, et al.
Publicado: (2019)

A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder
por: Maneeton N, et al.
Publicado: (2014)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Mazen K Ali, et al.
Publicado: (2011)

A network meta-analysis of the dose–response effects of lurasidone on acute schizophrenia
por: Manit Srisurapanont, et al.
Publicado: (2021)

Evaluating the Effect of Preoperative Duloxetine Administration on Postoperative Pain in Patients under Abdominal Hysterectomy
por: H Sattari, et al.
Publicado: (2020)

COMPARATIVE STUDY OF EFFECTIVENESS OF VENLAFAXINE, DULOXETINE AND SERTRALINE IN MANAGEMENT OF DIABETIC SENSORY NEUROPATHY
por: Nabila Shaukat, et al.
Publicado: (2021)

A meta-analysis comparing short-term weight and cardiometabolic changes between olanzapine/samidorphan and olanzapine
por: Manit Srisurapanont, et al.
Publicado: (2021)

Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series
por: Yamaguchi Y, et al.
Publicado: (2018)

Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies
por: Elsenosy FM, et al.
Publicado: (2020)

Prevalence and predictors of depression in patients with systemic lupus erythematosus: a cross-sectional study
por: Maneeton B, et al.
Publicado: (2013)

Efficacy and safety of generic escitalopram (Lexacure®) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
por: Jeong JH, et al.
Publicado: (2015)

The noradrenergic paradox: implications in the management of depression and anxiety
por: Montoya A, et al.
Publicado: (2016)

A Scoping Review to Find Out Worldwide COVID-19 Vaccine Hesitancy and Its Underlying Determinants
por: Md. Rafiul Biswas, et al.
Publicado: (2021)

Delirium after a traumatic brain injury: predictors and symptom patterns
por: Maneewong J, et al.
Publicado: (2017)

Comparative efficacy and safety of Crocus sativus L. for treating mild to moderate major depressive disorder in adults: a meta-analysis of randomized controlled trials
por: Yang XY, et al.
Publicado: (2018)